Predictors of employment loss in ankylosing spondylitis

Results from the Scotland Registry For Ankylosing Spondylitis

Research output: Contribution to journalAbstract

Original languageEnglish
Pages (from-to)75-76
Number of pages2
JournalRheumatology
Volume55
Issue numberSuppl. 1
DOIs
Publication statusPublished - 24 Apr 2016
EventAnnual Meeting of the British-Society-for-Rheumatology, British-Health-Professionals-in-Rheumatology and the British-Society-for-Paediatric-and-Adolescent-Rheumatology (Rheumatology) - Glasgow
Duration: 26 Apr 201628 Apr 2016

Cite this

@article{0419c38a71cf4a118d9a2b9c0ee50c54,
title = "Predictors of employment loss in ankylosing spondylitis: Results from the Scotland Registry For Ankylosing Spondylitis",
author = "Dean, {Linda E.} and Macfarlane, {Gary J.} and Ejaz Pathan and Jones, {Gareth T.}",
note = "G.J.M. has received honoraria from Pfizer and research funding from AbbVie, Pfizer and UCB. G.T.J. has received research funding from AbbVie, Pfizer and UCB. All other authors have declared no conflicts of interest.",
year = "2016",
month = "4",
day = "24",
doi = "10.1093/rheumatology/kew132.006",
language = "English",
volume = "55",
pages = "75--76",
journal = "Rheumatology",
issn = "1462-0324",
publisher = "OXFORD UNIV PRESS INC",
number = "Suppl. 1",

}

TY - JOUR

T1 - Predictors of employment loss in ankylosing spondylitis

T2 - Results from the Scotland Registry For Ankylosing Spondylitis

AU - Dean, Linda E.

AU - Macfarlane, Gary J.

AU - Pathan, Ejaz

AU - Jones, Gareth T.

N1 - G.J.M. has received honoraria from Pfizer and research funding from AbbVie, Pfizer and UCB. G.T.J. has received research funding from AbbVie, Pfizer and UCB. All other authors have declared no conflicts of interest.

PY - 2016/4/24

Y1 - 2016/4/24

U2 - 10.1093/rheumatology/kew132.006

DO - 10.1093/rheumatology/kew132.006

M3 - Abstract

VL - 55

SP - 75

EP - 76

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

IS - Suppl. 1

ER -